Treatment with rituximab in idiopathic membranous nephropathy

BACKGROUND: Rituximab represents a valid therapeutic option to induce remission in patients with primary glomerulonephritis. Despite several studies proving its efficacy in improving outcomes in patients with membranous nephropathy (MN), its role in therapeutic protocols is not yet defined. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorentino, Marco, Tondolo, Francesco, Bruno, Francesca, Infante, Barbara, Grandaliano, Giuseppe, Gesualdo, Loreto, Manno, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Glomerulopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5162414/
https://www.ncbi.nlm.nih.gov/pubmed/27994855
http://dx.doi.org/10.1093/ckj/sfw091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5162414/
https://www.ncbi.nlm.nih.gov/pubmed/27994855
http://dx.doi.org/10.1093/ckj/sfw091

Ejemplares similares